A detailed history of Brinker Capital Investments, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 3,559 shares of MEDP stock, worth $2.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,559
Previous 4,717 24.55%
Holding current value
$2.1 Million
Previous $1.48 Million 23.58%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$308.88 - $514.16 $357,683 - $595,397
-1,158 Reduced 24.55%
3,559 $1.83 Million
Q2 2025

Aug 27, 2025

SELL
$277.23 - $315.28 $12.1 Million - $13.8 Million
-43,639 Reduced 90.25%
4,717 $1.48 Million
Q2 2025

Aug 14, 2025

BUY
$277.23 - $315.28 $12.1 Million - $13.8 Million
43,786 Added 958.12%
48,356 $15.2 Million
Q1 2025

Jul 31, 2025

BUY
$304.69 - $360.97 $98,110 - $116,232
322 Added 7.58%
4,570 $1.39 Million
Q4 2024

Jul 31, 2025

BUY
$308.93 - $363.58 $1.02 Million - $1.2 Million
3,299 Added 347.63%
4,248 $1.41 Million
Q3 2024

Jul 31, 2025

BUY
$320.58 - $457.29 $130,476 - $186,117
407 Added 75.09%
949 $316,000
Q2 2024

Jul 31, 2025

BUY
$372.0 - $424.34 $6,324 - $7,213
17 Added 3.24%
542 $223,000
Q1 2024

Jul 31, 2025

SELL
$284.87 - $413.31 $90,018 - $130,605
-316 Reduced 37.57%
525 $212,000
Q4 2023

Jul 31, 2025

SELL
$227.52 - $312.68 $53,012 - $72,854
-233 Reduced 21.69%
841 $257,000
Q4 2022

Feb 06, 2023

BUY
$153.06 - $226.57 $164,386 - $243,336
1,074 New
1,074 $228,000
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $166,366 - $256,743
-1,198 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$182.74 - $227.9 $218,922 - $273,024
1,198 New
1,198 $261,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $18.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.